FDA says patients can self-administer Covid-19 tests, but not at home
New guidance from the FDA this week would make it easier for patients to self-test for Covid-19. But the agency still hasn’t approved home testing.
Optum’s John Muir Health deal provides a new model for health system collaboration
As part of the deal, Optum will take over non-clinical functions for the provider ranging from IT services, revenue cycle management, analytics and claims processing and bring on more than 500 John Muir Health employees.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
UnitedHealth’s $4.3B DaVita Medical acquisition wins conditional FTC approval
The effort by the nation's largest insurer to become the nation's largest employer of clinicians received FTC approval with an agreement to divest some of the company's holdings in the Las Vegas area to address antitrust issues.
UnitedHealth and CVS Health pose largest threat to healthcare providers, survey says
According to a nationwide survey conducted by Kaufman Hall, 67 percent of respondents considered the nation's largest insurer as either a strong or extreme competitive threat to hospitals and health systems over the next five years.
UnitedHealth Group cuts purchase price for DaVita assets by $560M
The companies said the new price was due to a decline in the financial status of the medical group, along with a desire to expedite the process of obtaining clearance from the Federal Trade Commission.
Deals roundup: Optum acquires surgical group, Aledade lands $20M
UnitedHealthGroup's OptumCare subsidiary is acquiring Surgical Care Affiliates for $2.3 billion, Takeda is ponying up $5.2 billion to acquire Ariad Pharmaceuticals, while Aledade closed on a $20 million funding round.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.